ProPhase Labs Inc. | Ownership

Companies that own ProPhase Labs Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BML Capital Management LLC
298,302
2.58%
-329,020
2.69%
12/31/2017
Renaissance Technologies LLC
188,699
1.64%
31,499
0%
06/30/2018
The Bank of New York Mellon Corp. (Investment Management)
118,154
1.02%
0
0%
06/30/2018
Northern Trust Investments, Inc.
41,341
0.36%
-3,306
0%
06/30/2018
PNC Bank, NA (Investment Management)
25,402
0.22%
0
0%
06/30/2018
The Vanguard Group, Inc.
22,228
0.19%
2,900
0%
06/30/2018
Acadian Asset Management LLC
21,419
0.19%
2,934
0%
06/30/2018
BlackRock Fund Advisors
20,132
0.17%
14,654
0%
06/30/2018
DWS Investment GmbH
20,099
0.17%
20,099
0%
06/30/2018
UBS Financial Services, Inc.
15,586
0.14%
-1,500
0%
06/30/2018

About ProPhase Labs

View Profile
Address
621 North Shady Retreat Road
Doylestown Pennsylvania 18901
United States
Employees -
Website http://www.prophaselabs.com
Updated 07/08/2019
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products, dietary supplements, and other remedies. Its products include TK supplement and Organix Rx. The company was founded by Guy J.